首页>
外国专利>
Identification of thrombosis or risk of bleeding in an individual with and without antiplatelet therapy
Identification of thrombosis or risk of bleeding in an individual with and without antiplatelet therapy
展开▼
机译:识别使用和不使用抗血小板治疗的个体中的血栓形成或出血风险
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention relates to a method for identification of an individual at increased risk of thrombosis or an atherothrombotic event, or a major bleeding event, comprising a step of assaying a biological sample from the individual for the presence of a SNP in the PPARGC1², CNTN4, LZTS1 and KCNE4 genes, wherein the presence of a SNP in the PPARGC1², CNTN4, LZTS1 and KCNE4 genes correlates with the individual being at increased risk of thrombosis or an atherothrombotic event, or a major bleeding event. Typically, the SNP is selected from the SNPs provided in Tables 1 and 2. The invention also provides a method of identifying an individual most likely to gain benefit from single anti-platelet therapy in the primary prevention of cardiovascular events, a method of identifying an individual most likely to gain benefit from dual anti-platelet therapy in the secondary prevention of cardiovascular events, and a method of identifying an individual likely to suffer a significant bleeding complication when undergoing treatment with drugs which influence haemostasis.
展开▼